TrialArthritis & rheumatology (Hoboken, N.J.)2025

Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China.

Jia Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.